TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2 - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS
Article Dans Une Revue Molecular Cancer Année : 2023

TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2

André Baruchel
  • Fonction : Auteur

Résumé

The reintegration of excised signal joints resulting from human V(D)J recombination was described as a potent source of genomic instability in human lymphoid cancers. However, such molecular events have not been recurrently reported in clinical patient lymphoma/leukemia samples. Using a specifically designed NGS-capture pipeline, we here demonstrated the reintegration of T-cell receptor excision circles (TRECs) in 20/1533 (1.3%) patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). Remarkably, the reintegration of TREC recurrently targeted the tumor suppressor gene, ZFP36L2, in 17/20 samples. Thus, our data identified a new and hardly detectable mechanism of gene deregulation in lymphoid cancers providing new insights in human oncogenesis.
Fichier principal
Vignette du fichier
Balducci et al 2023.pdf (1.51 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04237392 , version 1 (11-10-2023)

Identifiants

Citer

Estelle Balducci, Thomas Steimlé, Charlotte Smith, Patrick Villarese, Mélanie Feroul, et al.. TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2. Molecular Cancer, 2023, 22 (1), pp.108. ⟨10.1186/s12943-023-01794-y⟩. ⟨hal-04237392⟩
116 Consultations
50 Téléchargements

Altmetric

Partager

More